ST. LOUIS--(BUSINESS WIRE)--GenoMed™ (OTC Pink Sheets:GMED), the Next Generation Disease Management company whose business is public health™, announced today that its approach to avian influenza ("bird flu") has been published by the prestigious journal Annals of Internal Medicine.